ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DCPH Deciphera Pharmaceuticals Inc

25.59
0.00 (0.00%)
18 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Deciphera Pharmaceuticals Inc DCPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 25.59 10:00:00
Open Price Low Price High Price Close Price Previous Close
25.59 25.59
more quote information »

Recent News

Date Time Source Heading
14/6/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
12/6/202410:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202410:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202410:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202410:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202410:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202410:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202410:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202407:18EDGAR2Form S-8 POS - Securities to be offered to employees in..
12/6/202407:02EDGAR2Form POS AM - Post-Effective amendments for registration..
12/6/202407:01EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
11/6/202423:25EDGAR2Form 8-K - Current report
11/6/202423:18EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/6/202423:15EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
03/6/202421:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
03/6/202421:00BWDeciphera Pharmaceuticals Announces Oral Presentation of..
28/5/202420:08EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
22/5/202423:06EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
22/5/202421:01EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
13/5/202420:32EDGAR2Form SC 14D9 - Solicitation, recommendation statements
13/5/202420:31EDGAR2Form SC TO-T - Tender offer statement by Third Party
10/5/202421:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202407:16EDGAR2Form SC TO-C - Written communication relating to an issuer..
29/4/202421:00BWDeciphera Pharmaceuticals to be Acquired by ONO..
09/4/202421:00BWDeciphera Pharmaceuticals to Present at the Stifel 2024..
27/2/202423:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
21/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202408:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202423:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/2/202423:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202423:10EDGAR2Form 8-K - Current report
06/2/202423:00BWDeciphera Pharmaceuticals Announces Fourth Quarter and Full..
02/2/202408:50BWDeciphera Pharmaceuticals to Announce Fourth Quarter and..
01/2/202423:00BWDeciphera Pharmaceuticals to Present at the Guggenheim..
19/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202403:13BWDeciphera Pharmaceuticals Presents Long-Term Follow-Up..
08/1/202423:14EDGAR2Form 8-K - Current report
08/1/202423:00BWDeciphera Pharmaceuticals Announces Planned 2024 Corporate..
05/1/202423:00BWDeciphera Pharmaceuticals Announces Nature Medicine..
02/1/202423:00BWDeciphera Pharmaceuticals to Present at the 42nd Annual J.P...
15/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock